Annals of the American Thoracic Society
Scope & Guideline
Shaping the future of respiratory medicine with cutting-edge insights.
Introduction
Aims and Scopes
- Pulmonary Diseases and Disorders:
The journal covers a wide range of topics related to various pulmonary conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and pulmonary hypertension, with an emphasis on both clinical and translational research. - Critical Care Medicine:
Research in this area includes studies on managing critically ill patients, with a focus on respiratory failure, mechanical ventilation, and the impact of critical illness on long-term outcomes. - Sleep Medicine:
The journal publishes work on sleep-disordered breathing, including obstructive sleep apnea, its impact on overall health, and treatment strategies. - Public Health and Environmental Impacts:
Research addressing the intersections of respiratory health with public health issues, such as air pollution, smoking cessation, and health disparities, is a significant focus. - Innovative Therapeutics:
The journal highlights studies on novel therapeutic approaches, including biologics and pharmacological treatments for various pulmonary conditions. - Multidisciplinary Approaches:
Research that involves collaborative efforts across specialties, including insights from epidemiology, genetics, and health services research, is emphasized to address complex pulmonary issues.
Trending and Emerging
- Impact of COVID-19 on Respiratory Health:
A significant surge in studies related to the long-term effects of COVID-19 on pulmonary health, including post-COVID syndrome and its management, reflects the ongoing repercussions of the pandemic on respiratory care. - Telemedicine and Remote Patient Monitoring:
The rise of telehealth practices, particularly post-COVID-19, is leading to an increase in research on the effectiveness and implementation of telemedicine in managing chronic respiratory conditions. - Health Disparities and Equity:
There is an increasing focus on health equity, particularly regarding race, socioeconomic status, and access to care, as well as the impact of social determinants of health on pulmonary outcomes. - Artificial Intelligence and Machine Learning Applications:
Emerging research is increasingly utilizing AI and machine learning to improve diagnostics, treatment strategies, and predictive modeling in respiratory diseases. - Environmental Health and Respiratory Disease:
A growing body of literature examines the effects of environmental factors, including air pollution and climate change, on respiratory health, emphasizing the need for interdisciplinary approaches. - Personalized Medicine in Pulmonary Care:
There is a notable trend towards personalized approaches in treatment, particularly in asthma and COPD management, involving genetic, phenotypic, and biomarker-driven strategies.
Declining or Waning
- Traditional Epidemiological Studies:
There has been a noticeable decrease in the publication of traditional epidemiological studies that do not incorporate newer methodologies or technologies, such as big data analytics or machine learning, which are increasingly in demand. - Basic Science Research:
Although foundational research remains important, there appears to be a waning interest in purely laboratory-based studies without direct clinical implications, as the focus shifts towards translational research with immediate applications in patient care. - Single-Disease Focus:
Research that concentrates on single diseases in isolation is becoming less common, with a broader trend towards studies that consider comorbid conditions and the interconnectedness of various pulmonary disorders. - Outdated Treatment Protocols:
As new guidelines and treatment modalities emerge, older treatment protocols and their efficacy are being phased out, leading to fewer studies focused on traditional management strategies. - Non-comprehensive Health Disparities Studies:
Research focusing solely on health disparities without integrating social determinants of health or systemic factors has seen a decline, as the field moves towards more holistic approaches.
Similar Journals
Therapeutic Advances in Respiratory Disease
Advancing Knowledge in Respiratory HealthTherapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Enhancing clinical outcomes through impactful research.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
Pulmonology
Unleashing the latest in pulmonary and respiratory medicine.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Chronic Respiratory Disease
Championing open access for global respiratory research.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
LUNG
Exploring the complexities of lung diseases for better patient outcomes.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
Turkish Thoracic Journal
Connecting global insights to Turkish thoracic challenges.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
BMJ Open Respiratory Research
Driving breakthroughs in respiratory health for a healthier tomorrow.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Respiratory Care
Transforming Research into Respiratory Solutions.Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.
Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine
Connecting Researchers and Practitioners in Clinical MedicineClinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.
BMC Pulmonary Medicine
Advancing respiratory health through open access research.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.